Aggregated
67% success rate- Bullish
- 0
- Hold
- 0
- Bearish
- 0
LUCID CAPITAL MARKETS
An analyst at LUCID CAPITAL MARKETS with 8 tracked ratings across 8 distinct tickers has a 66.7% success rate on the captured sample, covering two sources.
Methodology differs by source. Track records are aggregated from multiple sources; scoring methodology and scales differ by source and values are not directly comparable. Coverage is sourced from publicly-aggregated analyst activity. Past performance does not guarantee future results. Not investment advice.
| Ticker | Date | Rating | Price target | Source |
|---|---|---|---|---|
| SNSE | 2026-05-28 | buy | $50.00 | Aggregated |
| NXTC | 2026-05-11 | buy | $25.00 | Aggregated |
| RLMD | 2026-03-02 | buy | $14.00 | Aggregated |
| LYEL | 2025-09-26 | buy | $20.00 | Aggregated |
| LYELLYELL IMMUNOPHARMA INC | 2025-09-26 | unknown | $20.00 | Aggregated |
| ADAG | 2025-09-18 | buy | $9.00 | Aggregated |
| ADAGADAGENE INC - ADR | 2025-09-18 | unknown | $9.00 | Aggregated |
| GNLX | 2025-07-21 | buy | $10.00 | Aggregated |
| GNLXGENELUX CORP | 2025-07-21 | unknown | $10.00 | Aggregated |
| Ticker | Ratings | Last rating | Sources |
|---|---|---|---|
| SNSE | 1 | 2026-05-28 | Aggregated |
| NXTC | 1 | 2026-05-11 | Aggregated |
| RLMD | 1 | 2026-03-02 | Aggregated |
| LYEL | 1 | 2025-09-26 | Aggregated |
| LYELLYELL IMMUNOPHARMA INC | 1 | 2025-09-26 | Aggregated |
| ADAG | 1 | 2025-09-18 | Aggregated |
| ADAGADAGENE INC - ADR | 1 | 2025-09-18 | Aggregated |
| GNLX | 1 | 2025-07-21 | Aggregated |
| GNLXGENELUX CORP | 1 | 2025-07-21 | Aggregated |